|Articles|May 31, 2017
TD2 and Deep 6 AI Announce Partnership
Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis.
Advertisement
Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis to match eligible patients with the appropriate clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
2
When AI Learns to Speak Every Language: An eCOA Migration Study
3
Using Digital Tools to Enhance Patient-Centric Trials
4
Preparing for End-to-End AI-Enabled Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
